PHARMAXIS has announced a
new sales and marketing agreement
for the commercialisation of
Bronchitol for cystic fibrosis in
Europe, ahead of the drug’s
anticipated regulatory approval.
The new six-year agreement has
been signed with Quintiles which
will be responsible for the launch
and commercilisation of the drug in
Europe.
“This important development
means that Pharmaxis will move into
the key European markets with a
clear commercialisation plan,” said
Pharmaxis acting ceo, Gary Phillips.The above article was sent to subscribers in Pharmacy Daily's issue from 31 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Aug 10
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.